MedTrace Logo

PET Imaging Study on Occupancy of Dopamine D2 Receptors and Genotypes After Bupropion Administration

NCT00846339 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-02-23

No results posted yet for this study

Summary

Bupropion has different effects on D2 dopamine receptors according to genotype.

Conditions

  • Smoking

Interventions

DRUG

Bupropion

bupropion

Sponsors & Collaborators

  • Ministry of Health, Welfare and Family Affairs

    collaborator UNKNOWN

  • Korea National Enterprise for Clinical Trials

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Kyung-Sang Yu, MD · Seoul National Univeristy Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-03-31
Completion
2009-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00846339 on ClinicalTrials.gov